Jensen-Roberts S, Myers TL, Auinger P, Cannon P, Rowbotham HM, Coker D, Chanoff E, Soto JM, Pawlik M, Amodeo K, Sharma S, Valdovinos B, Wilson RM, Sarkar A, McDermott MP, Alcalay RN, Biglan K, Kinel D, Tanner C, Winter-Evans R, Augustine EF, Holloway RG, Dorsey ER, Schneider RB. A Remote Longitudinal Observational Study of Individuals at Genetic Risk for Parkinson Disease: Baseline Results. Neurology Genetics. 2022; 8(5). doi: 10.1212/NXG.0000000000200008.
Soto JM,
Jensen-Roberts S,
Myers TL,
Pawlik M,
Hartman EA,
Lettenberger S,
Kaplan A, Toor R,
Wilson RM,
Auinger P,
Dorsey ER, Valdovinos B,
Amodeo K,
Sharma S,
Holloway RG, Tanner C, Alcalay RN,
Schneider RB.
Newly Identified Cases of Parkinsonism and Prodromal PD in a Remote LRRK2 G2019S Cohort.
International Congress of Parkinson’s Disease and Movement Disorders. September 2022.
Lettenberger S, Soto JM, Jensen-Roberts S, Myers TL, Pawlik M, Hartman EA, Kaplan A, Wilson RM, Auinger P, Dorsey ER, Valdovinos B, Amodeo K, Sharma S, Holloway RG, Alcalay RN, Schneider RB. Transparency in Health Research Results in LRRK2 Carriers Evaluated Longitudinally. Parkinson’s Study Group. June 2022.
Hartman EA, Soto JM, Jensen-Roberts S, Myers TL, Pawlik M, Lettenberger S, Kaplan A, Wilson RM, Auinger P, Dorsey ER, Valdovinos B, Amodeo K, Sharma S, Islam MS, Abdelkader A, Rahman W, Antony VN, Hoque E, Holloway RG, Alcalay RN, Schneider RB. Retention of a LRRK2 Cohort and Implementation of a Sub-Study to Identify Early Signs of Parkinson’s Disease. Parkinson’s Study Group. June 2022.
Soto JM, Jensen-Roberts S, Myers TL, Pawlik M, Hartman EA, Lettenberger S, Kaplan A, Wilson RM, Auinger P, Dorsey ER, Valdovinos B, Amodeo K, Sharma S, Holloway RG, Tanner C, Alcalay RN, Schneider RB. Remote Follow Up of Prodromal Parkinson's Disease in a LRRK2 G2019S Cohort. American Academy of Neurology Annual Meeting. April 2022.
Soto JM, Jensen-Roberts S, Myers TL, Pawlik M, Moore J, Sarkar A, Wilson RM, Auinger P, Dorsey ER, Valdovinos B, Amodeo K, Sharma S, Holloway RG, Rowbotham HM, Chanoff E, Alcalay RN, Schneider RB. Remote Assessment of Parkinson's Disease in a LRRK2 G2019S Cohort. International Association of Parkinsonism and Related Disorders. September 2021.
Jensen-Roberts S, Waddell E, Myers TL, Pawlik M, Soto JM, Sarkar A, Coffey M, Stevenson EA, Wilson RM, Dorsey ER, Lizarraga K, Tarolli C, Schneider RB, Adams JL. Technology-Based Adaptation of a Natural History Study of Parkinson Disease During the COVID-19 Pandemic. International Association of Parkinsonism and Related Disorders. September 2021.
Jensen-Roberts S, Myers TL, Soto JM, Pawlik M, Wilson RM, Amodeo K, Sharma S, Valdovinos B, Alcalay RN, Holloway RG, Schneider RB. Baseline characteristics of LRRK2 G2019S carriers in the Virtual Assessment of LRRK2 carriers to Optimize Research in Parkinson’s Disease (VALOR-PD) Study. American Academy of Neurology Annual Meeting. April 2021.
Schneider RB, Myers TL, Rowbotham HM, Luff MK, Amodeo K, Sharma S, Wilson RM, Jensen-Roberts S, Auinger P, McDermott MP, Alcalay RN, Biglan K, Kinel DR, Tanner C, Winter-Evans R, Augustine EF, Cannon P; 23andMe Research Team, Holloway RG, Dorsey ER. A Virtual Cohort Study of Individuals at Genetic Risk for Parkinson's Disease: Study Protocol and Design. Journal of Parkinson's Disease. 2020; 10(3): 1195-1207. doi: 10.3233/JPD-202019.
Myers TL, Schneider RB, Jensen-Roberts S, Rowbotham HM, Luff MK, Chanoff, E, Amodeo K, Sharma S, Alcalay RN, Cannon P, Dorsey ER, Holloway RG. Recruitment of a Virtual Nationwide Cohort of LRRK2 G2019S Carriers. American Academy of Neurology Annual Meeting. April 2020.
Schneider RB, Myers TL, Dorsey ER, Holloway, RG. A Virtual Cohort Study of LRRK2 G2019S Carriers: A Novel Model for Long-Term Observation. American Academy of Neurology Annual Meeting. May 2019.